Back to top

Alnylam price target raised to $485 from $470 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Alnylam (ALNY) to $485 from $470 and keeps a Buy rating on the shares after AstraZeneca (AZN) and...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Alnylam Pharmaceuticals, Inc. (ALNY)

AstraZeneca PLC (AZN)

Ionis Pharmaceuticals, Inc. (IONS)